|
ANO6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.72089999997505E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.93139995294945E-09 |
| Normal-vs-Stage2 |
1.420840E-01 |
| Normal-vs-Stage3 |
3.717200E-01 |
| Normal-vs-Stage4 |
9.833000E-01 |
| Stage1-vs-Stage2 |
6.954200E-02 |
| Stage1-vs-Stage3 |
8.082200E-03 |
| Stage1-vs-Stage4 |
2.466800E-01 |
| Stage2-vs-Stage3 |
6.736200E-01 |
| Stage2-vs-Stage4 |
5.856600E-01 |
| Stage3-vs-Stage4 |
7.310600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.97820000000537E-06 |
| Normal-vs-AfricanAmerican |
6.579800E-04 |
| Normal-vs-Asian |
4.537600E-03 |
| Caucasian-vs-AfricanAmerican |
8.986600E-01 |
| Caucasian-vs-Asian |
7.202000E-01 |
| AfricanAmerican-vs-Asian |
6.511800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.2791999660684E-09 |
| Normal-vs-Female |
7.285200E-01 |
| Male-vs-Female |
2.162500E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.002800E-03 |
| Normal-vs-Extreme_Weight |
3.47660000787897E-09 |
| Normal-vs-Obese |
1.257790E-01 |
| Normal-vs-Extreme_Obese |
3.86850000000383E-05 |
| Normal_Weight-vs-Extreme_Weight |
2.414200E-01 |
| Normal_Weight-vs-Obese |
2.355600E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.438200E-01 |
| Extreme_Weight-vs-Obese |
5.418600E-03 |
| Extreme_Weight-vs-Extreme_Obese |
6.155400E-01 |
| Obese-vs-Extreme_Obese |
1.124800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.644200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.276100E-03 |
| Normal-vs-Age(61-80Yrs) |
6.70620003972999E-09 |
| Normal-vs-Age(81-100Yrs) |
9.851600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.592800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.075050E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.716200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.161720E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.311400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.269600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.51119999741911E-09 |
| Normal-VS-Type2 PRCC |
2.904000E-03 |
| Normal-VS-KIRP CIMP |
1.099970E-01 |
| Normal-VS-Unclassified PRCC |
1.720990E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.345900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.795650E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.209800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.728100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.293000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.599700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.27120000000558E-05 |
| Normal-vs-N1 |
9.383600E-01 |
| Normal-vs-N2 |
3.227800E-01 |
| N0-vs-N1 |
6.393700E-02 |
| N0-vs-N2 |
1.846810E-01 |
| N1-vs-N2 |
1.081160E-01 |
|
|
